CCIA
Campbell & Co Investment Adviser’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,258
| Closed | -$359K | – | 1019 |
|
|
2024
Q4 | $359K | Buy |
+11,258
| New | +$359K | 0.03% | 785 |
|
|
2024
Q2 | – | Sell |
-38,024
| Closed | -$2.24M | – | 1036 |
|
|
2024
Q1 | $2.24M | Buy |
+38,024
| New | +$2.24M | 0.19% | 117 |
|
|
2023
Q3 | – | Sell |
-9,850
| Closed | -$897K | – | 926 |
|
|
2023
Q2 | $897K | Buy |
9,850
+1,545
| +19% | +$141K | 0.16% | 192 |
|
|
2023
Q1 | $548K | Buy |
+8,305
| New | +$548K | 0.1% | 385 |
|
|
2022
Q4 | – | Sell |
-17,177
| Closed | -$1.17M | – | 759 |
|
|
2022
Q3 | $1.17M | Buy |
17,177
+11,650
| +211% | +$796K | 0.27% | 95 |
|
|
2022
Q2 | $250K | Buy |
+5,527
| New | +$250K | 0.07% | 526 |
|